Cent

R&D spending per NME declines

R&D spending per NME declines

According to a recent survey, the pharma industry spent an
estimated $1.25 billion for each new molecular entity (NME)
approved by the FDA in 2004. The figure represents the second
consecutive year in which this figure has declined...

Euro chemicals gather momentum

Euro chemicals gather momentum

UK chemical sector growth, including pharmaceuticals, is forecast
at 3.6 per cent for 2004, outperforming the 2.3 per cent growth
estimated for Europe as a whole, according to a study presented at
the Chemical Industry Association's...

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers